Core Insights - The Xinjiang Shawan City Market Supervision Bureau organized a training meeting to enhance the quality and safety regulation of pharmaceuticals and medical devices, aiming to improve risk prevention capabilities among enterprises and ensure public safety in medication and medical device usage [1][3] Group 1: Meeting Overview - The meeting was attended by 76 participants, including heads and quality managers of pharmaceutical and medical device enterprises, as well as regulatory personnel from various market supervision offices [1] - Typical cases of drug circulation and medical device operation were discussed to analyze industry risks and alert enterprises to the importance of adhering to their responsibilities [1] Group 2: Key Focus Areas - The meeting summarized the work related to pharmaceuticals and medical devices for 2025, identified existing issues, and outlined key tasks for 2026, including specialized training [1] - Training covered legal regulations, quality management, and warning cases to enhance the business capabilities and compliance awareness of pharmaceutical and medical device enterprises [3] Group 3: Future Actions - The Xinjiang Shawan City Market Supervision Bureau plans to intensify the investigation of risks and adopt a zero-tolerance approach towards illegal activities, aiming to improve the quality and safety management level of pharmaceuticals and medical devices in the city [3]